Avrio Ventures invests $2M in Biopharmacopae to further advance the commercialization of RIDOVIR™Cold and other product discoveries

QUEBEC CITY, Feb. 21 /CNW Telbec/ - Biopharmacopae Design International Inc. ("Biopharmacopae"), a company specialized in the discovery and development of innovative, science-based, plant-derived ingredients and products for the nutraceutical and cosmeceutical industries, announced today that it has closed a $2 Million private financing round with Canadian venture capital firm Avrio Ventures. This second round of financing from Avrio Ventures confirms the company's growth potential. The funds will contribute to further advance the commercialization of Biopharmacopae's flagship product RIDOVIR™ Cold and its other discoveries in the Canadian and International markets.

Biopharmacopae recently launched RIDOVIR™ Cold, a new cough and cold natural health product in several Canadian pharmacies. In addition, the company joined forces with well-known pharmacist and health expert Jean-Yves Dionne. The company is currently expanding its presence in the market by establishing additional commercial agreements with other pharmacies and large retail stores. "Biopharmacopae holds a portfolio of extremely promising products with significant market potential, and their recent studies on the antiviral activity of their cough and cold natural health product, RIDOVIR™ Cold, are very encouraging, says Mr. Aki Georgacacos, Partner at Avrio Ventures. In addition, with the company's expertise and recent discovery, Biopharmacopae is well-positioned within the industry to become a strategic partner for companies looking for innovative products with great market potential."

"We have created a technology platform adapted to the discovery of new health benefits related to plants and this gives us a competitive advantage when it comes to developing innovative health and beauty solutions" explains Dr. Johane Guay, Ph.D., Biopharmacopae's President and CEO. Dr. Guay stated that she is extremely grateful for Avrio's financial support and business and industry-related knowledge. "The solidity of our partnership with Avrio as well as their expertise and support are great assets to the existing strengths of the company. Together, we are currently pursuing further clinical research studies and intensifying our commercial efforts for RIDOVIR™ Cold in Canada and on the export markets."

About Biopharmacopae

Biopharmacopae is a Canadian company known for the superior quality of its innovative plant-derived active ingredients and products. These products and ingredients are distributed through a worldwide network of partners recognized in the cosmetic and natural health product markets. The company develops and manufactures its products and active ingredients using a rigorous pharmaceutical approach that scientifically demonstrates their safety and efficacy. The company distinguishes itself with its original collection of over 15,000 plant extracts and with its exclusive technology platform, eXcelerate that allows for the rapid screening of thousands of plant extracts, highlighting their specific beneficial effects on human health. Biopharmacopae contributes to the advancement of science and improvement of the quality of life by developing natural products and ingredients that combine tradition and innovation.

About Avrio Ventures Management Corporation

Avrio Ventures provides Canada's promising industrial bioproducts, nutraceutical ingredients and food technology companies with the investment support and resources they need to succeed. With a collective 80 years of experience in Canada's industrial life science venture capital sector through the successes of FCC Ventures, a division of Farm Credit Canada, and Kirchner Investment Management Corporation, the Avrio team is well equipped with deep, sector-specific knowledge. Also providing strategic guidance, operational skills and access to industry relationship's the Avrio team is uniquely qualified to support an entrepreneurial industrial life sciences organization throughout its growth.

About Mr Jean-Yves Dionne

Jean-Yves Dionne is a pharmacist, a scientific advisor and consultant in the natural health product (NHP) industry for several companies and professional groups. His research focuses on the interaction between NHPs and drugs as well as on conventional medicine and complementary or alternative medicine. He is the author or co-author of several books, including "Herbs, Everyday Reference for Health Professionals".

SOURCE Biopharmacopae

For further information:

Sources:
Lyne Dubois, MBA, Sales and Marketing Director
Biopharmacopae Design International Inc.

Aki Georgacacos, Partner
Avrio Ventures

Contact :
Isabelle Saillant, Parenthèses Communications
Tel.: 418 527-4537; isabelle@parenthesescom.ca

Expert Advisor:
Jean-Yves Dionne
Tel.: 514 733-4779;  jyd@apothicaire.ca

Profil de l'entreprise

Biopharmacopae

Renseignements sur cet organisme

Avrio Ventures Management Corporation

Renseignements sur cet organisme


FORFAITS PERSONNALISÉS

Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .

ADHÉSION À CNW

Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.

RENSEIGNEZ-VOUS SUR LES SERVICES DE CNW

Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.